Chapter 5 Flashcards

(29 cards)

1
Q

__________ are safe and effective alternatives to brand name prescription

A

Generic drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Advantage of generic drug:

A

can help both consumers and the government reduce the cost of prescription drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Brand drug / original:

A
  1. Chemistry
  2. Manufacturing
  3. Controls
  4. Labeling
  5. Testing
  6. Animal Studies
  7. Clinical Studies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Generic drug:

A
  1. Chemistry
  2. Manufacturing
  3. Controls
  4. Labeling
  5. Testing
  6. Bioequivalence Study (In Vivo, In vitro) - مهمة تنعمل لكل دواء مصنع
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Definitions/ requirements- Generic drug:

A
  1. Same active ingredient
  2. Same rout of administration
  3. Same strength (concentration)
  4. Same indication (use)
  5. Same dosage form
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

___________ is a drug product approved in a new drug application according to the FDA regulation, based on full reports of
investigations of safety and effectiveness.

A

RLD- Reference listed drug (brand drug)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

_______ absences of a significant different in rate and extent which the active ingredient in pharmaceutical equivalents

A

Bioequivalence
هي انه ما يكون في فرق بين البراند والجينيرك بال rate وهي وينتا وصل الدم وال extent قدي وصل الدم وقتها بسميهن equivalence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

___________ pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study.

A

Bioequivalence
- same rate and extent for both drug generic and extent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Goals of bioequivalence:
- to ensure product on the market is comparable to that upon which the efficacy is based:

A
  1. Establishe that a new generic drug has therapeutic equivalence in rate and extent of absorption to the reference drug product.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The factors that may lead to differences between drugs have a same active ingredient: (low bioavailability- bio in equivalence)

A
  1. Dissolution
  2. Absorption
  3. Metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

________ The rate and extent at which its active ingredient is delivered from pharmaceutical form and becomes available in the systemic circulation

A

Bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

4 possible differences between the brand and the generic drug:

A

صفحة 11 ضروري

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Study design for bioavailability:

A

We take two groups (10 animals each).
First, one group gets the brand drug, the other gets the generic drug.
We collect blood and creat the curve.
After that, we perform a crossover , switch the first group gets the generic, the second gets the brand.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Effective and safety

A

If the generic drug reaches the bloodstream with the same extent and rate as the brand drug, then its effect and safety will be the same, and there is no need for animal testing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the purpose of the two-way crossover?

A
  1. Reduce number of experimental animal
  2. Reduce bias
  3. Reduce variation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Duration of washout / withdrawal period for cross-over design:

A

should be approximately > 5 times the plasma apparent terminal half-life
Why?
- To ensure that the first dose is no longer present in the blood and does not affect the results of the second dose.

15
Q

Study single dose:

A

In case crossover is difficult or the drug has a long withdrawal period, we use a single-dose design: each group receives only one type of the drug.

16
Q

Bioequivalence of drug:

A

80% - 125% T/R = اذا كانت الادوية بين هاي الفترات فهني مكافئات
- Confidence interval

17
Q

Measurement drug concentration, Method Validation should include الطريقة الي دفحص فيها لازم تضمن

A
  1. Accuracy
    2.sensitivity
  2. Specificity
  3. Recovery
  4. Stability
18
Q

______ Closeness of determined value to the true value

19
Q

________ The limit of quantitation is the lowest concentration which can be measured with acceptable accuracy and precision.

20
Q

________ Ability of the method to measure only what it is intended to measure in the presence of other components in the sample.

A

(Specificity )Selectivity

21
Q

__________ During, sample collection , sample storage and sample analysis process, the stability of drug in matrix should be conducted.

22
Q

Shelf life:

A

The period during which the drug’s amount does not decrease below 95% of its initial concentration.

23
High Performance Liquid Chromatography (HPLC)
HPLC works by pumping a liquid sample through a column (stationary phase), using a liquid (mobile phase) under high pressure. Different compounds in the sample exit the column at different times — called retention times. According to size and polarity
24
_______ processes can be defined as separation techniques involving mass-transfer between stationary and mobile phases.
Chromatographic
25
The time taken for a particular compound to travel through the column to the detector is known as its __________
Retention time
26
Basic HPLC Components
1. Mobile phase - Solvents) that carry the sample through the column. 2. Pump - Pushes the mobile phase and sample through the system. 3. Stationary phase (Column) - Where separation occurs according to size and polarity. 4. Detector - Measures the compound as it comes out of the column.
27
How to Read HPLC Results (Chromatogram):
- is a graph showing the Y-axis which shows how much of a compound is detected vs. time (x-axis). 1. Retention time 2. Peak concentration - The system stores the retention time and peak data of drugs as standards.